Koen Vermeulen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Autism Spectrum Disorder

Gas Chromatography

Top Venues

EJNMMI radiopharmacy and chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony Waked, Melissa Crabbé, Virginie Neirinckx, Sunay Rodriguez Pérez, Jasmien Wellens, Bernard Rogister, M Abderrafi Benotmane, Koen Vermeulen
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Anthony Waked, Melissa Crabbé, Virginie Neirinckx, Sunay Rodriguez Pérez, Jasmien Wellens, Bernard Rogister, M Abderrafi Benotmane, Koen Vermeulen
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Anthony Waked, Melissa Crabbé, Virginie Neirinckx, Sunay Rodriguez Pérez, Jasmien Wellens, Bernard Rogister, M Abderrafi Benotmane, Koen Vermeulen
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Nathalie Heynickx, Charlotte Segers, Amelie Coolkens, Sarah Baatout, Koen Vermeulen
Characterization of Non-Specific Uptake and Retention Mechanisms of [ 177 Lu]Lu-PSMA-617 in the Salivary Glands. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE. Pharmaceutics 14 (12) (2022)